삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

비뇨의학과 이현무 교수

진료분야
전립선암, 로봇수술, 전립선암하이푸(HIFU)시술, PSA(전립선암표지자)이상소견
진료일정 03 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
진료일정 04 月
날짜
토
01
일
02
월
03
화
04
수
05
목
06
금
07
토
08
일
09
월
10
화
11
수
12
목
13
금
14
토
15
일
16
월
17
화
18
수
19
목
20
금
21
토
22
일
23
월
24
화
25
수
26
목
27
금
28
토
29
일
30
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
1994.02 서울대학교 대학원 의학과 (박사)
1988.02 서울대학교 대학원 의학과 (석사)
1984.02 서울대학교 의과대학 졸업 (의학사)

경력

경력
2004.09 ~현재 성균관대학교 의과대학 비뇨의학과 교수
1988.04 ~현재 비뇨의학과 전문의 자격 취득
2010.04 ~ 2016.01 삼성서울병원 로봇수술센터장
2009.09 ~ 2015.03 삼성서울병원 비뇨의학과 과장 및 주임교수
2009.03 ~ 2015.03 삼성서울병원 비뇨암센터장
2011.08 ~ 2013.07 KBS 의료 자문 위원
2007.11 ~ 2008.01 미국 UC Irvine Medical Center 연수
2003.09 ~ 2004.08 성균관대학교 삼성서울병원 비뇨의학과 임상교수
2003.04 ~ 2003.08 성균관대학교 삼성서울병원 비뇨의학과 임상부교수
1996.03 ~ 2003.04 원자력병원 비뇨의학과 과장
2001.04 ~ 2002.12 원자력병원 교육수련부장
1998.03 ~ 2002.08 서울대학교 의과대학 초빙교원
2000.07 ~ 2001.01 미국 UCLA대학병원 연수
1991.05 ~ 1996.02 충북대학교 의과대학 비뇨의학과 전임강사 및 조교수
1989.04 ~ 1991.04 국군수도병원 지도전문의(군의관)
1985.03 ~ 1988.02 서울대학교병원 비뇨의학과 레지던트 과정 수료
1984.03 ~ 1985.02 서울대학교병원 인턴 과정 수료

학회활동

학회활동
2017.10 ~ 2019.09 대한비뇨국소치료연구회 회장
2011.01 ~ 2011.12 아시아 태평양 전립선학회 이사
2009.03 ~ 2011.03 대한전립선학회 회장
2008.11 ~ 2010.11 대한비뇨의학회 수련이사
2008.08 ~ 2010.07 대한비뇨기종양학회 이사
2007.10 ~ 2009.03 대한전립선학회 재무이사
2006.09 ~ 2008.08 대한비뇨기종양학회 학술위원장
2005.10 ~ 2007.10 대한전립선학회 총무이사
2003.10 ~ 2005.09 대한전립선학회 간행위원장
논문
  • PLOS ONE 2021 10.1371/journal.pone.0249709 Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value Chung1, JH; Jeong, JY; Lee, JY; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-87573-5 Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma Kim1, TH; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • BIOLOGY-BASEL 2021 10.3390/biology10040297 Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities Chung1, JH; Park, M; Cho, H; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-85099-4 Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma Kim1, YJ; Kang, Y; Kim, JS; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Park, D; Park, WY; Kang, M
    View PubMed
  • INVESTIG CLIN UROL 2021 10.4111/icu.20200406 Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance Yu1, J; Cho, E; Choi, J; Lim, JE; Lee, J; Kang, M; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.20200084 Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL Choi1, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.20200214 Docetaxel rechallenge in metastatic castration-resistant prostate cancer A retrospective, single-center study Byeon1, S; Kim, H; Kim, J; Kwon, M; Hur, JY; Jeon, HG; Jeon, SS; Lee, HM; Park, SH
    View PubMed
  • J CANCER 2020 10.7150/jca.48062 Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors A Propensity-Score Matching Analysis Kang1, M; Choi, J; Kim, J; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Park, SH; Song, C; Seo, SI
    View PubMed
  • J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e342 Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL) Chung1, JH; Yu, J; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • PROSTATE INT 2020 10.1016/j.prnil.2020.03.003 Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients Ryoo1, H; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • INT J SURG 2020 10.1016/j.ijsu.2020.07.006 Relationship between robotic-assisted radical prostatectomy and retropubic radical prostatectomy in the learning curve of a single surgeon as a novice in radical prostatectomy A retrospective cohort study Song1, W; Lee, SW; Chung, JH; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • DIS MARKERS 2020 10.1155/2020/8887605 Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment Kang1, M; Shin, SJ; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • CANCERS 2020 10.3390/cancers12040866 Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study Lee1, HW; Cho, HH; Joung, JG; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Nam, DH; Park, WY; Kim, CK; Seo, SI; Park, H
    View PubMed
  • CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2019.07.014 Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors Shin1, SJ; Kim, T; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI; Kang, M
    View PubMed
  • J ENDOUROL 2019 10.1089/end.2019.0410 Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • MEDICINE 2019 10.1097/MD.0000000000017931 Stratification based on adverse laboratory/pathological features for predicting overall survival in patients undergoing radical prostatectomy A K-CaP registry-based analysis Park1, JS; Koo, KC; Choi, IY; Lee, JY; Hong, JH; Kim, CS; Lee, HM; Hong, SK; Byun, SS; Rha, KH; Chung, BH; Lee, KS
    View PubMed
  • INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.6.454 The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy Song1, W; Kang, M; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • WORLD J UROL 2019 10.1007/s00345-018-02617-2 Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer Choi1, YH; Yu, JW; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • UROL INT 2019 10.1159/000501527 Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy Lee1, CU; Sung, SH; Jang, CT; Kang, M; Sung, HH; Jeong, BC; Il Seo, S; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.604 Atezolizumab in Patients with Pretreated Urothelial Cancer: A Korean Single-Center, Retrospective Study Hur1, JY; Kim, Y; Kwon, GY; Kang, M; Sung, HH; Jean, HG; Jeong, BC; Seo, SI; Jean, SS; Lee, HM; Lee, SJ; Park, SH
    View PubMed
  • CUAJ-CAN UROL ASSOC 2019 10.5489/cuaj.5605 Detection of circulating tumor cells and their potential use as a biomarker for advanced renal cell carcinoma Kim1, TH; Kang, YT; Cho, YH; Kim, JH; Jeong, BC; Seo, SL; Jeon, SS; Lee, HM
    View PubMed
  • INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.4.227 Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing Kang1, M; Cho, E; Jang, J; Lee, J; Jeon, Y; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Jeon, HG
    View PubMed
  • INT J SURG 2019 10.1016/j.ijsu.2019.04.013 Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study Song1, W; Jeong, JY; Jeon, HG; Seo, SI; Jeon, SS; Choi, HY; Lee, HM; Sung, HH
    View PubMed
  • Cancer Manag Res 2019 10.2147/CMAR.S199432 Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion Lee1, CU; Kang, M; Kim, TJ; Na, JP; Sung, HH; Jeon, HG; Seo, S; Jeon, SS; Lee, HM; Jeong, BC
    View PubMed
  • J NATL COMPR CANC NE 2019 10.6004/jnccn.2018.7265 Is Primary Androgen Deprivation Therapy a Suitable Option for Asian Patients With Prostate Cancer Corn red With Radical Prostatectomy? Ha1, US; Choi, JB; Shim, JI; Kang, M; Park, E; Kang, S; Park, J; Yang, J; Choi, I; Ahn, J; Kwak, C; Jeong, CW; Kim, CS; Byun, SS; Seo, SI; Lee, HM; Lee, SJ; Lee, SH; Chung, BH; Lee, JY
    View PubMed
  • PROSTATE 2019 10.1002/pros.23766 A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation Choi1, YH; Han, DH; Kim, SW; Kim, MJ; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY
    View PubMed
  • BMC UROL 2019 10.1186/s12894-019-0463-7 A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naive prostate cancer Yoon1, SE; Kim, Y; Cho, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Lee, SJ; Park, SH
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-42739-0 Transperitoneal radical nephroureterectomy is associated with worse disease progression than retroperitoneal radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma Kim1, TH; Suh, YS; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Sung, HH
    View PubMed
  • CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2018.09.007 Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis Choi1, YH; Kang, MY; Sung, HH; Eon, HG; Jeong, BC; Seo, SI; Jeon, SS; Kim, CK; Park, BK; Lee, HM
    View PubMed
  • KOREAN J RADIOL 2019 10.3348/kjr.2018.0613 Prognostic Significance for Long-Term Outcomes Following Radical Prostatectomy in Men with Prostate Cancer: Evaluation with Prostate Imaging Reporting and Data System Version 2 Kim1, R; Kim, CK; Park, JJ; Kim, JH; Seo, SI; Jeon, SS; Lee, HM
    View PubMed
  • Cancer Manag Res 2019 10.2147/CMAR.S185796 Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients Yu1, J; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • DIAGN PATHOL 2019 10.1186/s13000-019-0782-8 Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy Choi1, YH; Yu, JW; Jeong, BC; Seo, S; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-018-36602-x Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma Kim1, JJ; Suh, YS; Kim, TH; Jeon, SS; Lee, HM; Choi, H; Kim, S; Lee, KS
    View PubMed
  • CLIN GENITOURIN CANC 2018 10.1016/j.clgc.2018.07.030 Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SIL
    View PubMed
  • J UROLOGY 2018 10.1016/j.juro.2018.06.030 Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy Kang1, M; Park, JY; Jeong, CW; Hwang, EC; Song, C; Hong, SH; Kwak, C; Chung, J; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-33464-1 Cytopathological Study of the Circulating Tumor Cells filtered from the Cancer Patients' Blood using Hydrogel-based Cell Block Formation Kang1, YT; Kim, YJ; Lee, TH; Cho, YH; Chang, HJ; Lee, HM
    View PubMed
  • MEDICINE 2018 10.1097/MD.0000000000012766 Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy A retrospective competing-risk analysis from the K-CaP registry Hah1, YS; Lee, KS; Choi, IY; Lee, JY; Hong, JH; Kim, CS; Lee, HM; Hong, SK; Byun, SS; Lee, SH; Rha, KH; Chung, BH; Koo, KC
    View PubMed
  • CLIN GENITOURIN CANC 2018 10.1016/j.clgc.2018.02.015 Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6 Song1, W; Bang, SH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Kim, CK; Lee, HM
    View PubMed
  • EUR RADIOL 2018 10.1007/s00330-018-5305-6 RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome Park1, BK; Gong, IH; Kang, MY; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • OncoTargets and therapy 2018 10.2147/OTT.S169094 The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study Song1, W; Yu, JW; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Kang, ES; Jeon, HG
    View PubMed
  • INT J UROL 2018 10.1111/iju.13574 Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma Kang1, M; Yu, J; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.008 Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract Lee1, JY; Kim, K; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Kwon, GY; Kim, KM; Lee, J; Lim, HY; Park, SH
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0191786 Comparisons of oncological outcomes and perioperative complications between laparoscopic and open radical nephrectomies in patients with clinical T2 renal cell carcinoma (>= 7cm) Lee1, H; Lee, CU; Yoo, JH; Sung, HH; Jeong, BC; Jeon, SS; Lee, HM; Choi, HY; Jeong, CW; Kwak, C; Il Seo, S
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2016.494 Re-stratification of Patients with High-Risk Prostate Cancer According to the NCCN Guidelines among Patients Who Underwent Radical Prostatectomy: An Analysis Based on the K-CaP Registry Lee1, KS; Koo, KC; Choi, IY; Lee, JY; Hong, JH; Kim, CS; Lee, HM; Hong, SK; Byun, SS; Rha, KH; Chung, BH
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2016.477 Selection Criteria for Active Surveillance of Patients with Prostate Cancer in Korea: A Multicenter Analysis of Pathology after Radical Prostatectomy Jeong1, CW; Hong, SK; Byun, SS; Jeon, SS; Seo, SI; Lee, HM; Ahn, H; Kwon, DD; Ha, HK; Kwon, TG; Chung, JS; Kwak, C; Kim, HJ
    View PubMed
  • ANN SURG ONCOL 2017 10.1245/s10434-017-6065-2 y Prognostic Significance of Pre- to Postoperative Dynamics of the Prognostic Nutritional Index for Patients with Renal Cell Carcinoma Who Underwent Radical Nephrectomy Kang1, M; Chang, CT; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Lee, HM
    View PubMed
  • CLIN GENITOURIN CANC 2017 10.1016/j.clgc.2017.05.008 Preoperative Cholesterol Level Is Associated With Worse Pathological Outcomes and Postoperative Survival in Localized Renal Cell Carcinoma Patients: A Propensity Score-Matched Study Lee1, H; Jeong, CW; Kwak, C; Kim, HH; Il Seo, S; Lee, HM; Oh, JJ; Lee, SC; Hong, SK; Lee, SE; Byun, SS
    View PubMed
  • J ENDOUROL 2017 10.1089/end.2017.0369 Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma Kang1, M; Gong, IH; Park, HJ; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • J CANCER RES CLIN 2017 10.1007/s00432-017-2502-7 Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee Song1, W; Lee, DH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Choi, HY; Kim, JW; Lee, S; Byun, SS; Jeong, CW; Kwak, C; Cho, JS; Ahn, H; Jeon, SS
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0186026 Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance Jeon1, HG; Yoo, JH; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Lee, HM; Ferrari, M; Brooks, JD; Chung, BI
    View PubMed
  • JPN J CLIN ONCOL 2017 10.1093/jjco/hyx101 Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry Koo1, KC; Lee, KS; Jeong, JY; Choi, IY; Lee, JY; Hong, JH; Kim, CS; Lee, HM; Hong, SK; Byun, SS; Lee, SH; Rha, KH; Chung, BH
    View PubMed
  • SURG ONCOL 2017 10.1016/j.suronc.2017.04.003 Endoscopic management of upper tract urothelial carcinoma: Improved prediction of invasive cancer using a ureteroscopic scoring model Jeon1, SS; Sung, HH; Jeon, HG; Han, DH; Jeong, BC; Seo, SI; Lee, HM; Choi, HY
    View PubMed
  • CLIN GENITOURIN CANC 2017 10.1016/j.clgc.2017.01.015 Comparison of Oncologic Outcomes and Complications According to Surgical Approach to Radical Prostatectomy: Special Focus on the Perineal Approach Song1, W; Park, JH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY
    View PubMed
  • BMC UROL 2017 10.1186/s12894-017-0253-z A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer Kim1, HS; Lee, JY; Lee, SJ; Lim, HY; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Park, SH
    View PubMed
  • MEDICINE 2017 10.1097/MD.0000000000007223 Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naive, metastatic castration-resistant prostate cancer Kim1, CS; Choi, YD; Lee, SE; Lee, HM; Ueda, T; Yonese, J; Fukagai, T; Chiong, E; Lau, W; Abhyankar, S; Theeuwes, A; Tombal, B; Beer, TM; Kimura, G
    View PubMed
  • Asian J Androl. 2017 May-Jun;19(3):346-349. doi: 10.4103/1008-682X.172826. Mutation of MED12 is not a frequent occurrence in, prostate cancer of Korean patients Yoon N11, Lim S1, Kang SY1, Kwon GY1, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • J Urol. 2017 Apr;197(4):991-997. doi: 10.1016/j.juro.2016.10.055. Epub 2016 Oct 17. Postoperative Outcome of Cystic Renal Cell Carcinoma Defined on Preoperative Imaging: A Retrospective Study Park JJ11, Jeong BC2, Kim CK3, Seo SI2, Carriere KC4, Kim M5, Park BK6, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • Urol Oncol. 2017 Mar;35(3):114.e1-114.e7. doi: 10.1016/j.urolonc.2016.10.022. Epub 2016 Nov 28. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer Song W11, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • Int Urol Nephrol. 2017 Feb;49(2):191-196. doi: 10.1007/s11255-016-1458-x. Epub 2016 Nov 25. Clinical significance of incidentally detected bladder wall thickening on computed tomography Song W11, Jeon HG1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM2.
    View PubMed
  • Scand J Urol. 2017 Feb;51(1):27-32. doi: 10.1080/21681805.2016.1266384. Development of a new nomogram to predict insignificant prostate cancer in patients undergoing radical prostatectomy Kim TH11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Choi HY2, Lee HM2.
    View PubMed
  • J Korean Med Sci. 2016 Dec;31(12):1983-1988. doi: 10.3346/jkms.2016.31.12.1983. A Prospective Multicenter Trial of the Efficacy and Tolerability of Neoadjuvant Sunitinib for Inoperable Metastatic Renal Cell Carcinoma Kim SH11, Seo SI2, Lee HM2, Choi HY2, Jeon SH3, Lee HL3, Kwon TG4, Kim YJ5, Kim WJ5, Chung J6.
    View PubMed
  • Oncotarget. 2016 Dec 13;7(50):83735-83743. doi: 10.18632/oncotarget.13407. Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer Song W11, Kwon GY2, Kim JH3, Lim JE4, Jeon HG1, Il Seo S1, Jeon SS1, Choi HY1, Jeong BC1, Lee HM1.
    View PubMed
  • Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E377-E382. doi: 10.5489/cuaj.3896. Epub 2016 Nov 10. Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients Kim TH11, Kim CK2, Park BK2, Jeon HG3, Jeong BC3, Seo SI3, Lee HM3, Choi HY3, Jeon SS3.
    View PubMed
  • Oncotarget. 2016 Sep 27;7(39):63870-63886. doi: 10.18632/oncotarget.11563. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2 Park BH11, Lim JE2, Jeon HG3, Seo SI3, Lee HM3, Choi HY3, Jeon SS3, Jeong BC3.
    View PubMed
  • Oncotarget. 2016 Aug 9;7(32):51626-51639. doi: 10.18632/oncotarget.10539. Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion Chang N11,2,3, Lee HW3,4, Lim JE5, Jeong DE1, Song HJ6, Kim S3,7, Nam DH1,2,3, Sung HH5, Jeong BC5, Seo SI5, Jeon SS5, Lee HM5, Choi HY5, Jeon HG5.
    View PubMed
  • J Endourol. 2016 Jul;30(7):783-91. doi: 10.1089/end.2015.0652. Epub 2016 May 26. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches Kim TH11, Sung HH2, Jeon HG2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeong BC2.
    View PubMed
  • J Clin Pathol. 2016 Jul;69(7):586-92. doi: 10.1136/jclinpath-2015-203314. Epub 2015 Dec 15. Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion Sung JY11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Kang SY3, Choi YL3, Kwon GY3.
    View PubMed
  • Int Urol Nephrol. 2016 Jun;48(6):977-83. doi: 10.1007/s11255-016-1250-y. Epub 2016 Feb 26. Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma Park BH11, Sung HH2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • Int J Urol. 2016 Jun;23(6):472-7. doi: 10.1111/iju.13077. Epub 2016 Mar 14. Comparison of preoperative adaptive enlargement of the contralateral normal kidney in patients nephrectomized for benign non-functioning kidney versus renal cell carcinoma Song W11, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG1.
    View PubMed
  • Sci Rep. 2016 May 5;6:25419. doi: 10.1038/srep25419. Is lymphovascular invasion a powerful predictor for biochemical recurrence in pT3 N0 prostate cancer? Results from the K-CaP database Park YH11, Kim Y2, Yu H2, Choi IY3, Byun SS4, Kwak C5, Chung BH6, Lee HM7, Kim CS8, Lee JY1.
    View PubMed
  • UROLOGY, APR 2016, 90:124-125, DOI: 10.1016/j.urology.2015.10.053 Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma REPLY Lee SW1, Il Seo S
    View PubMed
  • Urology. 2016 Apr;90:119-24. doi: 10.1016/j.urology.2015.10.051. Epub 2016 Jan 11. Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma Lee SW11, Sung HH1, Jeon HG1, Jeong BC1, Jeon SS1, Lee HM1, Choi HY1, Seo SI2.
    View PubMed
  • J Urol. 2016 Mar;195(3):568-73. doi: 10.1016/j.juro.2015.09.073. Epub 2015 Sep 26. Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of Results Jeon HG11, Seo SI1, Jeong BC1, Jeon SS1, Lee HM1, Choi HY1, Song C1, Hong JH1, Kim CS1, Ahn H1, Jeong IG2.
    View PubMed
  • World J Urol. 2016 Jan;34(1):63-8. doi: 10.1007/s00345-015-1551-2. Epub 2015 Apr 3. Volumetric measurement of compensatory hypertrophy in the contralateral normal kidney by the tumor growth Park BH11, Jeong BC2, Jeon SS2, Seo SI2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • World J Urol. 2016 Jan;34(1):83-8. doi: 10.1007/s00345-015-1592-6. Epub 2015 May 17. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma Song W11, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • Int J Urol. 2016 Jan;23(1):56-61. doi: 10.1111/iju.12960. Epub 2015 Oct 26. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy Song W11, Jeon HG1, Sung HH1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM1.
    View PubMed
  • Ann Surg Oncol. 2016 Jan;23(1):321-7. doi: 10.1245/s10434-015-4614-0. Epub 2015 Jun 5. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Renal Cell Carcinoma Patients Undergoing Nephrectomy Jeon HG11, Choi DK1, Sung HH1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM2.
    View PubMed
  • PLoS One. 2015 Nov 10;10(11):e0139976. doi: 10.1371/journal.pone.0139976. eCollection 2015. Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma Sung HH11, Jeon HG1, Han DH1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS1.
    View PubMed
  • Eur Radiol. 2015 Nov;25(11):3143-50. doi: 10.1007/s00330-015-3741-0. Epub 2015 May 8. Measurement of renal function in a kidney donor: a comparison of creatinine-based and volume-based GFRs Choi DK11, Choi SM1, Park BH2, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG3.
    View PubMed
  • PLoS One. 2015 Nov 24;10(11):e0141709. doi: 10.1371/journal.pone.0141709. eCollection 2015. Trends in the Use of Nephron-Sparing Surgery over 7 Years: An Analysis Using the RENAL Nephrometry Scoring System Shin SJ11, Ko KJ1, Kim TS1, Ryoo HS1, Sung HH1, Jeon HG1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS1.
    View PubMed
  • J Korean Med Sci. 2015 Nov;30(11):1631-7. doi: 10.3346/jkms.2015.30.11.1631. Epub 2015 Oct 16. Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer Lee HW11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • J Urol. 2015 Oct;194(4):910-5. doi: 10.1016/j.juro.2015.04.093. Epub 2015 Apr 28. Compensatory Structural and Functional Adaptation after Radical Nephrectomy for Renal Cell Carcinoma According to Preoperative Stage of Chronic Kidney Disease Choi DK11, Jung SB1, Park BH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • J Korean Med Sci. 2015 Sep;30(9):1321-7. doi: 10.3346/jkms.2015.30.9.1321. Epub 2015 Aug 13. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection Lee HW11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Choi HY2, Lee HM2.
    View PubMed
  • Eur Radiol. 2015 Jun;25(6):1786-92. doi: 10.1007/s00330-014-3566-2. Epub 2015 Jan 31. Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance Kim TH11, Jeong JY, Lee SW, Kim CK, Park BK, Sung HH, Jeon HG, Jeong BC, Seo SI, Lee HM, Choi HY, Jeon SS.
    View PubMed
  • Int J Cancer. 2015 May 1;136(9):2065-77. doi: 10.1002/ijc.29248. Epub 2014 Oct 10. Tpl2 induces castration resistant prostate cancer progression and metastasis Lee HW11, Cho HJ, Lee SJ, Song HJ, Cho HJ, Park MC, Seol HJ, Lee JI, Kim S, Lee HM, Choi HY, Nam DH, Joo KM.
    View PubMed
  • Int J Urol. 2015 May;22(5):455-61. doi: 10.1111/iju.12716. Epub 2015 Jan 29. Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy Lee HW11, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG.
    View PubMed
  • BJU Int. 2015 Apr;115(4):587-94. doi: 10.1111/bju.12846. Epub 2014 Dec 7. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma Sung HH11, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • PLoS One. 2015 Mar 23;10(3):e0122019. doi: 10.1371/journal.pone.0122019. eCollection 2015. A Comparison of Radiologic Tumor Volume and Pathologic Tumor Volume in Renal Cell Carcinoma (RCC) Choi SM11, Choi DK2, Kim TH2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • Clin Cancer Res. 2015 Mar 1;21(5):1172-82. doi: 10.1158/1078-0432.CCR-14-1589. Epub 2014 Dec 30. Patient-Derived Xenografts from Non-Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy Lee HW11, Lee JI2, Lee SJ3, Cho HJ2, Song HJ4, Jeong da E5, Seo YJ2, Shin S5, Joung JG6, Kwon YJ7, Choi YL8, Park WY9, Lee HM10, Seol HJ2, Shim YM11, Joo KM12, Nam DH13.
    View PubMed
  • Abdom Imaging. 2015 Mar;40(3):571-7. doi: 10.1007/s00261-014-0245-3. Comparison of re-biopsy with preceded MRI and re-biopsy without preceded MRI in patients with previous negative biopsy and persistently high PSA Park BK11, Jeon SS, Park B, Park JJ, Kim CK, Lee HM, Choi HY.
    View PubMed
  • J Korean Med Sci. 2015 Mar;30(3):317-22. doi: 10.3346/jkms.2015.30.3.317. Epub 2015 Feb 16. Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges Lee HW11, Jeon HG1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM1.
    View PubMed
  • J Korean Med Sci. 2015 Feb;30(2):180-5. doi: 10.3346/jkms.2015.30.2.180. Epub 2015 Jan 21. Rapid Increase of Health Care Utilization and Cost due to Benign Prostatic Hyperplasia in Korean Men: Retrospective Population-based Analysis Using the Health Insurance Review and Assessment Service Data Son H11, Park J1, Song SH2, Kang JY3, Hong SK4, Lee HM5, Kim SH6, Park BJ7, Lee HL8, Lee KS9.
    View PubMed
  • Int J Urol. 2015 Jan;22(1):82-7. doi: 10.1111/iju.12604. Epub 2014 Sep 10. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery Chang JH11, Park W, Park JS, Pyo H, Huh SJ, Choi HY, Lee HM, Jeon SS, Seo SI.
    View PubMed
  • Int J Urol. 2014 Dec;21(12):1239-44. doi: 10.1111/iju.12589. Epub 2014 Aug 6. Abiraterone acetate and prednisolone for metastatic castration-resistant prostate cancer failing androgen deprivation and docetaxel-based chemotherapy: A phase II bridging study in Korean and Taiwanese patients Kwak C11, Wu TT, Lee HM, Wu HC, Hong SJ, Ou YC, Byun SS, Rhim HY, Kheoh T, Wan Y, Yeh H, Yu MK, Kim CS.
    View PubMed
  • World J Urol. 2014 Dec;32(6):1523-9. doi: 10.1007/s00345-014-1312-7. Epub 2014 May 10. Transperitoneal versus retroperitoneal robotic partial nephrectomy: matched-pair comparisons by nephrometry scores Choo SH11, Lee SY, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    View PubMed
  • J Korean Med Sci. 2014 Dec;29(12):1688-93. doi: 10.3346/jkms.2014.29.12.1688. Epub 2014 Nov 21. Interval from Prostate Biopsy to Radical Prostatectomy Does Not Affect Immediate Operative Outcomes for Open or Minimally Invasive Approach Park B11, Choo SH2, Jeon HG3, Jeong BC3, Seo SI3, Jeon SS3, Lee HM3, Choi HY3.
    View PubMed
  • Urology. 2014 Nov;84(5):1001-7. doi: 10.1016/j.urology.2014.06.052. Epub 2014 Oct 24. Incidence and Management of Extended-spectrum Beta-lactamase and Quinolone-resistant Escherichia coli Infections After Prostate Biopsy Song W11, Choo SH1, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee KS1, Lee SW1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • J Urol. 2014 Jul;192(1):82-8. doi: 10.1016/j.juro.2014.01.005. Epub 2014 Jan 15. Influence of Magnetic Resonance Imaging in the Decision to Preserve or Resect Neurovascular Bundles at Robotic Assisted Laparoscopic Radical Prostatectomy Park BH11, Jeon HG1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS2.
    View PubMed
  • BJU Int.?2014 Jun;113(6):864-70. doi: 10.1111/bju.12423. Epub 2013 Dec 2. Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance Park BH11,?Jeon HG,?Choo SH,?Jeong BC,?Seo SI,?Jeon SS,?Choi HY,?Lee HM.
    View PubMed
  • AJR Am J Roentgenol. 2014 May;202(5):W459-65. doi: 10.2214/AJR.13.11381. Prostate Cancer: Role of Pretreatment Multiparametric 3-T MRI in Predicting Biochemical Recurrence After Radical Prostatectomy Park JJ11, Kim CK, Park SY, Park BK, Lee HM, Cho SW.
    View PubMed
  • Int J Urol.?2014 Apr;21(4):377-81. doi: 10.1111/iju.12326. Epub 2013 Oct 29. Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols Kim TH11,?Jeon HG,?Choo SH,?Jeong BC,?Seo SI,?Jeon SS,?Choi HY,?Lee HM.
    View PubMed
  • Yonsei Med J. 2014 Mar;55(2):310-5. doi: 10.3349/ymj.2014.55.2.310. Is High-Dose Leuprorelin Acetate Effective and Safe in Asian Men with Prostate Cancer An Open-Label, Non-Comparative, Multi-Center Clinical Trial Lee SH11, Lee HM, Kim SW, Lee ES, Hong SJ, Kim CS, Kang TW, Chung BH.
    View PubMed
  • Radiother Oncol. 2014 Feb;110(2):240-4. doi: 10.1016/j.radonc.2014.01.001. Epub 2014 Jan 28. Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy Park JS11, Park W2, Pyo HR1, Park BK3, Park SY3, Choi HY4, Lee HM4, Jeon SS4, Seo SI4, Jeong BC4, Jeon HG4.
    View PubMed
  • Urol Oncol. 2014 Jan;32(1):49.e23-31. doi: 10.1016/j.urolonc.2013.07.015. FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy Sung JY11, Sun JM2, Chang Jeong B3, Il Seo S3, Soo Jeon S3, Moo Lee H3, Yong Choi H3, Young Kang S4, Choi YL5, Young Kwon G6.
    View PubMed
  • J Clin Pathol.?2014 Jan;67(1):49-54. doi: 10.1136/jclinpath-2013-201799. Epub 2013 Aug 12. Clinical significance of micropapillary urothelial carcinoma of the upper urinary tract Sung HH11,?Cho J,?Kwon GY,?Jeon HG,?Jeong BC,?Seo SI,?Jeon SS,?Choi HY,?Lee HM.
    View PubMed
  • Eur J Cancer.?2014 Jan;50(1):64-9. doi: 10.1016/j.ejca.2013.08.018. Epub 2013 Sep 20. Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma Jeon HG11,?Choo SH1,?Sung HH1,?Jeong BC1,?Seo SI1,?Jeon SS1,?Choi HY1,?Lee HM2.
    View PubMed
  • J Urol. 2013 Jul;190(1):180-6. doi: 10.1016/j.juro.2013.01.057. Epub 2013 Jan 25. Desmopressin Add-On Therapy for Refractory Nocturia in Men Receiving alpha-Blockers for Lower Urinary Tract Symptoms Bae WJ11, Bae JH, Kim SW, Chung BH, Kim JH, Kim CS, Lee HM, Lee KS, Yoo TK, Kim SI, Byun SS, Lee JY.
    View PubMed
  • J Urol.?2013 Apr;189(4):1249-54. doi: 10.1016/j.juro.2012.11.043. Epub 2012 Nov 13. Uric Acid Levels Correlate with Baseline Renal Function and High Levels are a Potent Risk Factor for Postoperative Chronic Kidney Disease in Patients with Renal Cell Carcinoma Jeon HG11,?Choo SH,?Jeong BC,?Seo SI,?Jeon SS,?Choi HY,?Lee HM.
    View PubMed
  • Int J Cancer. 2013 Feb 1;132(3):625-34. doi: 10.1002/ijc.27639. Epub 2012 Jun 20. Body mass index and survival in patients with renal cell carcinoma: A clinical-based cohort and meta-analysis Choi Y11, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, Adami HO, Lee JE, Lee HM.
    View PubMed
  • J Korean Med Sci.?2013 Feb;28(2):227-36. doi: 10.3346/jkms.2013.28.2.227. Epub 2013 Jan 29. Influence of Body Mass Index, Smoking, and Blood Pressure on Survival of Patients with Surgically-Treated, Low Stage Renal Cell Carcinoma: A 14-Year Retrospective Cohort Study Park B11,?Jeong BC,?Seo SI,?Jeon SS,?Choi HY,?Lee HM.
    View PubMed
  • Br J Cancer.?2013 Feb 5;108(2):387-94. doi: 10.1038/bjc.2012.565. Epub 2013 Jan 8. Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma Choi Y11,?Park B,?Kim K,?Jeong BC,?Seo SI,?Jeon SS,?Choi HY,?Lee JE,?Lee HM.
    View PubMed
  • Prostate.?2012 Sep 15;72(13):1399-406. doi: 10.1002/pros.22491. Epub 2012 Jan 17. Seven years of experience with high-intensity focused ultrasound for prostate cancer: Advantages and limitations Sung HH11,?Jeong BC,?Seo SI,?Jeon SS,?Choi HY,?Lee HM.
    View PubMed
  • Urology. 2012 Jun;79(6):1379-84. doi: 10.1016/j.urology.2012.02.010. Epub 2012 Apr 13. Survey on Benign Prostatic Hyperplasia Distribution and Treatment Patterns for Men With Lower Urinary Tract Symptoms Visiting Urologists at General Hospitals in Korea: A Prospective, Noncontrolled, Observational Cohort Study Lee SH11, Chung BH, Kim CS, Lee HM, Kim CI, Yoo TK, Lee KS, Park KS, Byun SS, Yoon BI, Kim SW, Lee JY.
    View PubMed
  • Prostate. 2011 Oct 1;71(14):1525-37. doi: 10.1002/pros.21369. Epub 2011 Mar 3. Macrophages Induce Neuroendocrine Differentiation of Prostate Cancer Cells Via BMP6-IL6 Loop Lee GT11, Kwon SJ, Lee JH, Jeon SS, Jang KT, Choi HY, Lee HM, Kim WJ, Lee DH, Kim IY.
    View PubMed
  • Urology. 2011 Jan;77(1):171-6. doi: 10.1016/j.urology.2010.05.033. Epub 2010 Aug 5. Change in International Prostate Symptom Storage Subscore After Long-term Medical Therapy in BPH Patients: Finasteride and Alpha-blocker Combination Therapy in Men With Moderate-to-severe LUTS/BPH in Korea Lee JY11, Lee SH, Kim SJ, Kim CS, Lee HM, Kim CI, Chung BH.
    View PubMed
  • J Biol Chem. 2010 Dec 10;285(50):39401-8. doi: 10.1074/jbc.M110.103705. Epub 2010 Oct 1. Induction of Interleukin-6 Expression by Bone Morphogenetic Protein-6 in Macrophages Requires Both SMAD and p38 Signaling Pathways Lee GT11, Kwon SJ, Lee JH, Jeon SS, Jang KT, Choi HY, Lee HM, Kim WJ, Kim SJ, Kim IY.
    View PubMed
  • Scand J Urol Nephrol. 2010 Dec;44(6):399-405. doi: 10.3109/00365599.2010.508048. Epub 2010 Aug 13. Impacts of leuprolide acetate on quality of life in patients with prostate cancer: A prospective multicenter study You D11, Jeong IG, Kim SW, Chung BH, Cho JS, Lee HM, Yun SC, Kim CS.
    View PubMed
  • Urology.?2010 Dec;76(6):1425-9. doi: 10.1016/j.urology.2010.02.046. Epub 2010 Oct 13. Leiomyoma of the Urinary Bladder: A Series of Nine Cases and Review of the Literature Park JW11,?Jeong BC,?Seo SI,?Jeon SS,?Kwon GY,?Lee HM.
    View PubMed
  • J Endourol. 2010 Sep;24(9):1435-40. doi: 10.1089/end.2009.0638. Robot-Assisted Radical Cystectomy and Pelvic Lymph Node Dissection: A Multi-Institutional Study from Korea Kang SG11, Kang SH, Lee YG, Rha KH, Jeong BC, Ko YH, Lee HM, Seo SI, Kwon TG, Park SC, Jung SI, Sung GT, Kim HH.
    View PubMed
  • What Are Some New Developments in Prostate Cancer Diagnosis
    View PubMed
  • J Korean Med Sci.?2009 Dec;24(6):1139-44. doi: 10.3346/jkms.2009.24.6.1139. Epub 2009 Nov 9. The Utility of Fluorescence In Situ Hybridization for Detection of Bladder Urothelial Carcinoma in Routine Clinical Practice Kwak KW11,?Kim SH,?Lee HM.
    View PubMed
  • Cancer Genet Cytogenet. 2009 Apr 15;190(2):88-92. doi: 10.1016/j.cancergencyto.2008.12.011. The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men Song J11, Kim DY, Kim CS, Kim HJ, Lee DH, Lee HM, Ko W, Lee G.
    View PubMed
  • Significance of F-18-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma
    View PubMed
  • Invest Radiol.?2008 Nov;43(11):789-93. doi: 10.1097/RLI.0b013e318183725e. Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy Park BK11,?Lee HM,?Kim CK,?Choi HY,?Park JW.
    View PubMed
  • Urology.?2008 Apr;71(4):561-6. doi: 10.1016/j.urology.2007.11.057. Epub 2008 Feb 15. Efficacy of lidocaine spray as topical anesthesia for outpatient rigid cystoscopy in women: A prospective, randomized, double-blind trial Choe JH11,?Kwak KW,?Hong JH,?Lee HM.
    View PubMed
  • Prostate Cancer Prostatic Dis. 2006;9(4):439-43. Epub 2006 Jul 18. High-intensity focused ultrasound therapy for clinically localized prostate cancer Lee HM11, Hong JH, Choi HY.
    View PubMed
  • Int J Urol.?2006 Apr;13(4):442-4. Ureteral cancer associated with dermatomyositis Choi YS11,?Ryu KH,?Kwon GY,?Jeon SS,?Choi HY,?Lee HM.
    View PubMed
  • Int J Urol.?2006 Mar;13(3):305-7. Primary immature teratoma of the prostate with angiosarcoma component: Its unusual response to chemotherapy Lee HM11,?Song SY,?Park JO,?Kim BH.
    View PubMed